We are live on ! Find out more
RMTI icon

Rockwell Medical

33 hedge funds and large institutions have $3.56M invested in Rockwell Medical in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 13 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more call options, than puts

Call options by funds: $7K | Put options by funds: $4K

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

22% more capital invested

Capital invested by funds: $2.91M → $3.56M (+$649K)

3% more funds holding

Funds holding: 3233 (+1)

0.78% less ownership

Funds ownership: 2.47%1.69% (-0.78%)

46% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 13

Holders
33
Holders Change
+1
Holders Change %
+3.13%
% of All Funds
0.53%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
4
Increased
7
Reduced
13
Closed
3
Calls
$7K
Puts
$4K
Net Calls
+$3K
Net Calls Change
+$1K

RMTI Hedge Fund Activity: Q1 2023 in Review

33 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Rockwell Medical (RMTI) for Q1 2023, worth a combined $3.56M — up 22% from $2.91M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new RMTI positions and 3 closed out — a net gain of 1 holder — while 7 added to existing stakes and 13 trimmed.

The largest buyer was Raymond James & Associates, opening a new position worth an estimated $103K. The largest seller was Armistice Capital, cutting an estimated $1.46M.

  • 33 institutional investors held Rockwell Medical (RMTI) as of Q1 2023, up from 32 in Q4 2022.
  • Funds reported $3.56M of Rockwell Medical stock for Q1 2023, up 22% quarter-over-quarter.
  • 4 funds opened new Rockwell Medical positions in Q1 2023 and 3 closed out, a net change of +1 holder.
  • The largest Rockwell Medical buyer in Q1 2023 was Raymond James & Associates, an estimated $103K added.
  • The largest Rockwell Medical seller in Q1 2023 was Armistice Capital, an estimated $1.46M sold.

Based on aggregated 13F filings for Q1 2023.